Is Malignant Potential of Barrett's Esophagus Predictable by Endoscopy Findings?
- PMID: 33081277
- PMCID: PMC7602941
- DOI: 10.3390/life10100244
Is Malignant Potential of Barrett's Esophagus Predictable by Endoscopy Findings?
Abstract
Given that endoscopic findings can be used to predict the potential of neoplastic progression in Barrett's esophagus (BE) cases, the detection rate of dysplastic Barrett's lesions may become higher even in laborious endoscopic surveillance because a special attention is consequently paid. However, endoscopic findings for effective detection of the risk of neoplastic progression to esophageal adenocarcinoma (EAC) have not been confirmed, though some typical appearances are suggestive. In the present review, endoscopic findings that can be used predict malignant potential to EAC in BE cases are discussed. Conventional results obtained with white light endoscopy, such as length of BE, presence of esophagitis, ulceration, hiatal hernia, and nodularity, are used as indicators of a higher risk of neoplastic progression. However, there are controversies in some of those findings. Absence of palisade vessels may be also a new candidate predictor, as that reveals degree of intense inflammation and of cyclooxygenase-2 protein expression with accelerated cellular proliferation. Furthermore, an open type of mucosal pattern and enriched stromal blood vessels, which can be observed by image-enhanced endoscopy, including narrow band imaging, have been confirmed as factors useful for prediction of neoplastic progression of BE because they indicate more frequent cyclooxygenase-2 protein expression along with accelerated cellular proliferation. Should the malignant potential of BE be shown predictable by these endoscopic findings, that would simplify methods used for an effective surveillance, because patients requiring careful monitoring would be more easily identified. Development in the near future of a comprehensive scoring system for BE based on clinical factors, biomarkers and endoscopic predictors is required.
Keywords: Barrett’s esophagus; biomarkers; endoscopic predictor; endoscopic surveillance; esophageal adenocarcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1. Gastroenterology. 2016. PMID: 27702561 Review.
-
The value of medical imaging in uncomplicated and complicated Barrett's esophagus.Acta Gastroenterol Belg. 2000 Jan-Mar;63(1):22-8. Acta Gastroenterol Belg. 2000. PMID: 10907315 Review.
-
Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.Can J Surg. 2019 Apr 1;62(2):93-99. doi: 10.1503/cjs.008716. Can J Surg. 2019. PMID: 30907564 Free PMC article.
-
Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.J Gastroenterol. 2019 Nov;54(11):984-993. doi: 10.1007/s00535-019-01600-x. Epub 2019 Jun 25. J Gastroenterol. 2019. PMID: 31240437
-
Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.Dis Esophagus. 2017 Mar 1;30(3):1-5. doi: 10.1093/dote/dow025. Dis Esophagus. 2017. PMID: 28184470 Free PMC article.
Cited by
-
Construction of the Interaction Network of Hub Genes in the Progression of Barrett's Esophagus to Esophageal Adenocarcinoma.J Inflamm Res. 2023 Apr 12;16:1533-1551. doi: 10.2147/JIR.S403928. eCollection 2023. J Inflamm Res. 2023. PMID: 37077220 Free PMC article.
-
A case report of Barrett's esophageal adenocarcinoma in a young adult aged 20 years.DEN Open. 2025 Apr 7;5(1):e70111. doi: 10.1002/deo2.70111. eCollection 2025 Apr. DEN Open. 2025. PMID: 40196872 Free PMC article.
-
Endoscopic diagnosis and screening of Barrett's esophagus: Inconsistency of diagnostic criteria between Japan and Western countries.DEN Open. 2021 Nov 15;2(1):e73. doi: 10.1002/deo2.73. eCollection 2022 Apr. DEN Open. 2021. PMID: 35310704 Free PMC article. Review.
References
-
- Verbeek R.E., Leenders M., Ten Kate F.J., van Hillegersberg R., Vleggaar F.P., van Baal J.W., Van Oijen M.G.H., Siersema P.D. Surveillance of Barrett’s esophagus and mortality from esophageal adenocarcinoma: A population-based cohort study. Am. J. Gastroenterol. 2014;109:1215–1222. doi: 10.1038/ajg.2014.156. - DOI - PubMed
-
- Pech O., Behrens A., May A., Nachbar L., Gossner L., Rabenstein T., Manner H., Guenter E., Huijsmans J., Vieth M., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57:1200–1206. doi: 10.1136/gut.2007.142539. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials